Cidara Therapeutics Inc. Com New
13F holders, Q2 2024 (June 30)1holders −49
0new positions
29sold out
$0.92avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Cidara Therapeutics Inc. Com New in their 13F filings, down 49 from Q1 2024. 0 opened new positions and 29 sold out. The largest holder was Wetzel Investment Advisors, Inc. ($4K).
- Company
- Cidara Therapeutics Inc. Com New
- CUSIP
- 171757107
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 29 | $3.2M |
All 13F filers, Q1 2024 → Q2 2024: 3,492,511 shares sold, net −3,492,511 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Wetzel Investment Advisors, Inc. | 0.00% | No change | 4,000 | $4K |
"% of holder's portfolio" is CIDARA THERAPEUTICS INC COM NEW's weight in each manager's 13F, not the share of Cidara Therapeutics Inc. Com New the manager owns.